
|Articles|February 15, 2022
- Pharm Exec E-Books-03-08-2021
- Volume Sponsored eBook
- Issue 2
The Next Domino: Automation, AI, and touchless safety case processing
Author(s)Oracle
With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers
2
The Importance of Suppressor Cells in Tumor Progression
3
How the FDA Commissioner’s National Priority Vouchers Reshape Manufacturing, Pricing & Global Strategy
4
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer
5
